244 related articles for article (PubMed ID: 23800905)
1. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
[TBL] [Abstract][Full Text] [Related]
3. New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
Cristallini S; Hites M; Kabtouri H; Roberts JA; Beumier M; Cotton F; Lipman J; Jacobs F; Vincent JL; Creteur J; Taccone FS
Antimicrob Agents Chemother; 2016 Aug; 60(8):4750-6. PubMed ID: 27216073
[TBL] [Abstract][Full Text] [Related]
4. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
[TBL] [Abstract][Full Text] [Related]
5. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
Taccone FS; de Backer D; Laterre PF; Spapen H; Dugernier T; Delattre I; Wallemacq P; Vincent JL; Jacobs F
Int J Antimicrob Agents; 2011 Jun; 37(6):531-5. PubMed ID: 21489756
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
DelDot ME; Lipman J; Tett SE
Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
10. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
12. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
13. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Jamal JA; Udy AA; Lipman J; Roberts JA
Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
15. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
[TBL] [Abstract][Full Text] [Related]
17. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
19. Pursuing the Real Vancomycin Clearance during Continuous Renal Replacement Therapy in Intensive Care Unit Patients: Is There Adequate Target Attainment?
Smeets TJL; de Geus HRH; Rietveld A; Rietdijk WJR; Koch BCP; Endeman H; Hunfeld NGM
Blood Purif; 2023; 52(7-8):652-659. PubMed ID: 37311418
[TBL] [Abstract][Full Text] [Related]
20. Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
Burger R; Guidi M; Calpini V; Lamoth F; Decosterd L; Robatel C; Buclin T; Csajka C; Marchetti O
J Antimicrob Chemother; 2018 Dec; 73(12):3413-3422. PubMed ID: 30304491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
